Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.72
Bid: 48.00
Ask: 54.26
Change: 0.00 (0.00%)
Spread: 6.26 (13.042%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 53.72
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

1 Mar 2024 14:45

RNS Number : 3251F
Lloyds Bank PLC
01 March 2024
 

RNS Announcement

 

Lloyds Bank plc

 

Publication of Supplementary Prospectus

 

1 March 2024

 

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing.

 

Supplementary Prospectus dated 1 March 2024 (the Supplementary Prospectus) relating to the ?60,000,000,000 Global Covered Bond Programme of Lloyds Bank plc, unconditionally and irrevocably guaranteed as to payments of interest and principal by Lloyds Bank Covered Bonds LLP.

 

The Supplementary Prospectus should be read and construed in conjunction with the prospectus dated 3 August 2023, as supplemented by the supplementary prospectus dated 26 October 2023 (together, the Prospectus).

 

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/3251F_1-2024-3-1.pdf

 

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA.

For further information, please contact:

 

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Pascale Dorey

Director, Debt Investor Relations, Senior Funding and Covered Bonds

Email: pascale.dorey@lloydsbanking.com

 

 

+44 (0) 20 7356 1571

 

 

+44 (0) 20 7354 7402

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 7788 352 487

 

Lloyds Bank plcRegistered Office25 Gresham StreetLondon EC2V 7HN

 

Disclaimer - Intended Addressees

 

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

 

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States or to U.S. persons (as defined below) other than to qualified institutional buyers within the meaning of and in reliance on Rule 144A of the U.S. Securities Act of 1933, as amended (the Securities Act). The securities described herein have not been, and will not be, registered under the Securities Act or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and the Prospectus.

 

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFLFSSVSILIIS
Date   Source Headline
16th Nov 20224:30 pmRNSDirector/PDMR Shareholding
10th Nov 20223:30 pmRNSDirector/PDMR Shareholding
1st Nov 20229:43 amRNSDirector Declaration
31st Oct 20222:18 pmRNSTotal Voting Rights
27th Oct 202212:07 pmRNSPublication of Supplementary Prospectus
27th Oct 202212:01 pmRNS2022 Q3 Interim Management Statement
27th Oct 20227:00 amRNS2022 Q3 Interim Management Statement
12th Oct 20222:00 pmRNSDirector/PDMR Shareholding
12th Oct 20227:00 amRNSLBG COMPLETES SHARE BUYBACK PROGRAMME
11th Oct 20225:27 pmRNSTransaction in Own Shares
11th Oct 20229:06 amRNSLBG ANNOUNCES RESULTS OF TENDER OFFER
10th Oct 20225:39 pmRNSTransaction in Own Shares
7th Oct 20225:49 pmRNSTransaction in Own Shares
6th Oct 20225:46 pmRNSTransaction in Own Shares
5th Oct 20225:42 pmRNSTransaction in Own Shares
4th Oct 20225:46 pmRNSTransaction in Own Shares
3rd Oct 20225:11 pmRNSTransaction in Own Shares
30th Sep 20225:58 pmRNSTransaction in Own Shares
30th Sep 20224:09 pmRNSTotal Voting Rights
30th Sep 20222:00 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirectorate Change
29th Sep 20225:29 pmRNSTransaction in Own Shares
28th Sep 20225:39 pmRNSTransaction in Own Shares
27th Sep 20225:22 pmRNSTransaction in Own Shares
26th Sep 20225:36 pmRNSTransaction in Own Shares
23rd Sep 20225:40 pmRNSTransaction in Own Shares
23rd Sep 202212:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20229:18 amRNSNotice of Redemption
22nd Sep 20225:43 pmRNSTransaction in Own Shares
22nd Sep 20224:02 pmRNSDirector/PDMR Shareholding
21st Sep 20225:31 pmRNSTransaction in Own Shares
20th Sep 20225:22 pmRNSTransaction in Own Shares
16th Sep 20226:10 pmRNSTransaction in Own Shares
16th Sep 20221:47 pmRNS2022 Half-Year Results
15th Sep 20225:25 pmRNSTransaction in Own Shares
14th Sep 20225:29 pmRNSTransaction in Own Shares
14th Sep 20224:30 pmRNSDirector/PDMR Shareholding
13th Sep 20225:52 pmRNSTransaction in Own Shares
13th Sep 20222:00 pmRNSDirector/PDMR Shareholding
12th Sep 20225:37 pmRNSTransaction in Own Shares
12th Sep 20223:34 pmRNSLBG COMMENCES TENDER OFFER FOR ONE SERIES OF AT1
9th Sep 20225:43 pmRNSTransaction in Own Shares
8th Sep 20225:40 pmRNSTransaction in Own Shares
7th Sep 20225:23 pmRNSTransaction in Own Shares
6th Sep 20225:46 pmRNSTransaction in Own Shares
5th Sep 20225:43 pmRNSTransaction in Own Shares
2nd Sep 20225:16 pmRNSTransaction in Own Shares
1st Sep 20225:27 pmRNSTransaction in Own Shares
31st Aug 20225:28 pmRNSTransaction in Own Shares
31st Aug 20223:48 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.